Literature DB >> 21505139

Clinical inertia as a clinical safeguard.

Dario Giugliano1, Katherine Esposito.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 21505139     DOI: 10.1001/jama.2011.490

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  26 in total

1.  Efficacy and safety of insulin lispro protamine suspension as basal supplementation in patients with type 2 diabetes.

Authors:  Dario Giugliano; Katherine Esposito
Journal:  Ther Adv Endocrinol Metab       Date:  2012-06       Impact factor: 3.565

Review 2.  Evolution of lipid management guidelines: evidence might set you free.

Authors:  N John Bosomworth
Journal:  Can Fam Physician       Date:  2014-07       Impact factor: 3.275

3.  Home Blood Pressure Monitoring in Cases of Clinical Uncertainty to Differentiate Appropriate Inaction From Therapeutic Inertia.

Authors:  Sonal J Patil; Nuha K Wareg; Kelvin L Hodges; Jamie B Smith; Mark S Kaiser; Michael L LeFevre
Journal:  Ann Fam Med       Date:  2020-01       Impact factor: 5.166

4.  Therapeutic Inertia: Still a Long Way to Go That Cannot Be Postponed.

Authors:  Manel Mata-Cases; Josep Franch-Nadal; Mònica Gratacòs; Dídac Mauricio
Journal:  Diabetes Spectr       Date:  2020-02

Review 5.  Glycemic control in type 2 diabetes: from medication nonadherence to residual vascular risk.

Authors:  Dario Giugliano; Maria Ida Maiorino; Giuseppe Bellastella; Katherine Esposito
Journal:  Endocrine       Date:  2018-01-10       Impact factor: 3.633

6.  Guidelines, inertia, and judgment.

Authors:  Lawrence R Krakoff; Ian M Kronish
Journal:  Hypertension       Date:  2011-08-15       Impact factor: 10.190

7.  Does personalized diabetology overcome clinical uncertainty and therapeutic inertia in type 2 diabetes?

Authors:  Katherine Esposito; Antonio Ceriello; Dario Giugliano
Journal:  Endocrine       Date:  2013-03-12       Impact factor: 3.633

8.  Predictors of medication-related problems among medicaid patients participating in a pharmacist-provided telephonic medication therapy management program.

Authors:  Margie E Snyder; Caitlin K Frail; Heather Jaynes; Karen S Pater; Alan J Zillich
Journal:  Pharmacotherapy       Date:  2014-07-23       Impact factor: 4.705

9.  Overview of Therapeutic Inertia in Diabetes: Prevalence, Causes, and Consequences.

Authors:  Susan L Karam; Jared Dendy; Shruti Polu; Lawrence Blonde
Journal:  Diabetes Spectr       Date:  2020-02

10.  Glucose, cholesterol, and blood pressure: is lower always better for type 2 diabetes?

Authors:  Dario Giugliano; Maria Ida Maiorino; Giuseppe Bellastella; Katherine Esposito
Journal:  Endocrine       Date:  2016-05-25       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.